首页> 外文期刊>Hepatitis Monthly >SAFETY AND EFFECTIVENESS OF BLIND PERCUTANEOUS LIVER BIOPSY: ANALYSIS OF 1412 PROCEDURES
【24h】

SAFETY AND EFFECTIVENESS OF BLIND PERCUTANEOUS LIVER BIOPSY: ANALYSIS OF 1412 PROCEDURES

机译:经皮穿刺肝穿刺活检的安全性和有效性:1412程序分析

获取原文
           

摘要

Background: Percutaneous liver biopsy is one of the most important and widely used methods for diagnosing chronic liver diseases, however, controversies related to the potential risk of complications and patient discomfort still exist.Objectives: The objective of this study was to evaluate the safety and success rate of blind percutaneous liver biopsy.Patients and Methods: We conducted a retrospective analysis of 1412 blind percutaneous thick-needle liver biopsies performed during 1977-2000 at a single center on 1110 patients, using archived medical data of the center.Results: The overall success rate of obtaining a liver sample with this method was 95.3%. Of all the samples assessed, 91.7% were determined to be fully representative for an evaluation by the pathologist. Complications occurred in 259 procedures (18.3%). While no fatalities associated with liver biopsy were noted, 9 serious complications (0.64%) directly related to biopsies were reported. Pain was the most common complication (15.3%). Significantly more complications (pain and vasovagal reactions) were reported in females (22.1%) than in males (16.1%) (P=0.005). The rate of complications was significantly correlated with the stage of fibrosis (P=0.027), i.e. the higher the fibrosis stage, the higher the complication rate. Previous surgical procedures involving the abdominal cavity or thorax influenced the effectiveness of liver biopsy (P=0.017). Less operator experience was significantly associated with a higher rate of procedure failure (P=0.002). Statistical significance of the relationship between individual operator efficiency and complication rate (P=0.000) and that between individual operator efficiency and biopsy failure rate (P=0.002) was observed.Conclusions: Blind percutaneous liver biopsy is a safe and effective invasive procedure, despite the fact that noninvasive fibrosis assessment methods are currently widely available and used instead of histological evaluation. Complications risk and failure rate are low if indications and contraindications are considered carefully and the biopsy is performed by a skilled and experienced operator. Certain groups of patients may benefit from an image-guided procedure to improve its effectiveness.
机译:背景:经皮肝穿刺活检是诊断慢性肝病的最重要和广泛使用的方法之一,然而,与并发症和患者不适的潜在风险有关的争议仍然存在。目的:本研究的目的是评估安全性和安全性。病人和方法:我们回顾性分析了该中心的存档医学数据,对1110名患者在1977-2000年期间对1112位患者进行的1412例经皮穿刺厚针肝活检进行了回顾性分析。用这种方法获得肝脏样品的总成功率为95.3%。在所有评估的样品中,有91.7%被病理学家评估为完全具有代表性。 259例手术发生并发症(18.3%)。尽管未发现与肝活检相关的死亡,但有9例严重并发症(0.64%)与活检直接相关。疼痛是最常见的并发症(15.3%)。据报道,女性(22.1%)比男性(16.1%)有更多的并发症(疼痛和血管迷走反应)(P = 0.005)。并发症发生率与纤维化阶段显着相关(P = 0.027),即纤维化阶段越高,并发症发生率越高。先前涉及腹腔或胸腔的外科手术影响了肝活检的有效性(P = 0.017)。较少的操作者经验与较高的手术失败率显着相关(P = 0.002)。观察到个体操作者效率与并发症发生率之间的关系(P = 0.000)和个体操作者效率与活检失败率之间的关系(P = 0.002)的统计学意义。结论:尽管进行了盲法经皮肝穿刺活检是一种安全有效的侵入性手术非侵入性纤维化评估方法目前可广泛使用并代替组织学评估的事实。如果仔细考虑适应症和禁忌症,并由熟练且经验丰富的操作者进行活检,则并发症风险和失败率很低。某些患者组可能会受益于图像引导程序以提高其有效性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号